Marks Group Wealth Management Inc Acquires Shares of 1,667 Agilent Technologies, Inc. (NYSE:A)

Marks Group Wealth Management Inc acquired a new stake in Agilent Technologies, Inc. (NYSE:A) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 1,667 shares of the medical research company’s stock, valued at approximately $232,000.

Several other hedge funds also recently added to or reduced their stakes in A. OFI Invest Asset Management purchased a new stake in shares of Agilent Technologies during the third quarter worth about $25,000. MV Capital Management Inc. increased its position in shares of Agilent Technologies by 120.7% during the fourth quarter. MV Capital Management Inc. now owns 192 shares of the medical research company’s stock worth $27,000 after acquiring an additional 105 shares during the last quarter. Baystate Wealth Management LLC increased its position in shares of Agilent Technologies by 107.3% during the fourth quarter. Baystate Wealth Management LLC now owns 257 shares of the medical research company’s stock worth $36,000 after acquiring an additional 133 shares during the last quarter. Column Capital Advisors LLC increased its position in shares of Agilent Technologies by 1,111.1% during the third quarter. Column Capital Advisors LLC now owns 327 shares of the medical research company’s stock worth $37,000 after acquiring an additional 300 shares during the last quarter. Finally, Rosenberg Matthew Hamilton increased its position in shares of Agilent Technologies by 51.1% during the fourth quarter. Rosenberg Matthew Hamilton now owns 284 shares of the medical research company’s stock worth $39,000 after acquiring an additional 96 shares during the last quarter.

Analysts Set New Price Targets

A has been the topic of a number of analyst reports. Evercore ISI lifted their target price on Agilent Technologies from $132.00 to $145.00 and gave the stock an “in-line” rating in a research report on Thursday, April 4th. Barclays lifted their target price on Agilent Technologies from $125.00 to $135.00 and gave the stock an “underweight” rating in a research report on Wednesday, April 10th. Citigroup boosted their price objective on Agilent Technologies from $130.00 to $145.00 and gave the company a “neutral” rating in a report on Wednesday, February 28th. UBS Group boosted their price objective on Agilent Technologies from $130.00 to $155.00 and gave the company a “neutral” rating in a report on Wednesday, February 28th. Finally, Oppenheimer boosted their price objective on Agilent Technologies from $67.00 to $90.00 and gave the company an “outperform” rating in a report on Tuesday, March 26th. One analyst has rated the stock with a sell rating, five have issued a hold rating and twelve have given a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $141.29.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, CEO Michael R. Mcmullen sold 52,297 shares of the company’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $150.00, for a total value of $7,844,550.00. Following the completion of the sale, the chief executive officer now directly owns 253,909 shares in the company, valued at $38,086,350. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Agilent Technologies news, CEO Michael R. Mcmullen sold 52,297 shares of the company’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $150.00, for a total value of $7,844,550.00. Following the completion of the sale, the chief executive officer now directly owns 253,909 shares in the company, valued at $38,086,350. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Heidi Fields sold 1,658 shares of the company’s stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $144.34, for a total value of $239,315.72. Following the completion of the sale, the director now owns 54,976 shares of the company’s stock, valued at $7,935,235.84. The disclosure for this sale can be found here. Over the last three months, insiders sold 61,610 shares of company stock worth $9,220,333.

Agilent Technologies Stock Performance

Shares of A stock opened at $139.14 on Wednesday. The company has a quick ratio of 2.04, a current ratio of 2.68 and a debt-to-equity ratio of 0.41. The business has a 50 day moving average of $141.40 and a two-hundred day moving average of $130.28. Agilent Technologies, Inc. has a 52 week low of $96.80 and a 52 week high of $151.58. The company has a market cap of $40.77 billion, a P/E ratio of 33.13, a PEG ratio of 4.06 and a beta of 1.11.

Agilent Technologies (NYSE:A) last issued its earnings results on Tuesday, February 27th. The medical research company reported $1.29 EPS for the quarter, beating analysts’ consensus estimates of $1.22 by $0.07. The company had revenue of $1.66 billion during the quarter, compared to the consensus estimate of $1.59 billion. Agilent Technologies had a return on equity of 27.09% and a net margin of 18.35%. Agilent Technologies’s quarterly revenue was down 5.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.37 earnings per share. As a group, analysts anticipate that Agilent Technologies, Inc. will post 5.5 EPS for the current year.

Agilent Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 24th. Stockholders of record on Tuesday, April 2nd will be given a dividend of $0.236 per share. The ex-dividend date of this dividend is Monday, April 1st. This represents a $0.94 annualized dividend and a dividend yield of 0.68%. Agilent Technologies’s dividend payout ratio is presently 22.38%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.